The COVID-19 vaccine developed by BioNTech and Pfizer is likely to protect against the highly infectious variant of the virus, originally found in the UK, according to the results of a study released on Wednesday.The study, published on bioRxiv.org prior to peer review, showed that antibodies in the blood of